Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serologic Responses to 7-valent PCV in HIV Patients
NCT00885625Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2009
- Primary completion
- Apr 2010
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pneumococcal 7-valent conjugate vaccine in invasive pneumococcal disease (IPD) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: 2-fold increase of antibody titers specific to pneumococcal serotypes at 48 weeks. Status: unknown.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on NCT00885625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885625.